Concepedia

Mark Harnett

MH

Statistics

Publications

15

Citations

618

H-Index

13

Active since

2004

Affiliations

Lotus Clinical Research(Current)

Cleveland Clinic

Roivant Sciences (United States)

Myovant Sciences (United States)

Therapeutics Clinical Research

Mark Harnett is an author at Lotus Clinical Research specializing in medicine, sleep, and urology.

ORCID

Top concepts

Publications per year

2004–2021

15

Publications

15

Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial

Elizabeth Berry‐Kravis, Mark Harnett, Scott A. Reines et al. · Nature Medicine · 2021 · 126 citations

, , +5

Randomised clinical trial: the safety and tolerability of<i>Trichuris suis</i>ova in patients with Crohn's disease

William J. Sandborn, David E. Elliott, Joel V. Weinstock et al. · Alimentary Pharmacology & Therapeutics · 2013 · 121 citations

THE OVERACTIVE BLADDER-SYMPTOM COMPOSITE SCORE: A COMPOSITE SYMPTOM SCORE OF TOILET VOIDS, URGENCY SEVERITY AND URGE URINARY INCONTINENCE IN PATIENTS WITH OVERACTIVE BLADDER

Norman R. Zinner, Mark Harnett, LuAnn Sabounjian et al. · The Journal of Urology · 2005 · 70 citations

Pharmacokinetics and Safety of Long‐Acting Testosterone Undecanoate Injections in Hypogonadal Men: An 84‐Week Phase III Clinical Trial

Christina Wang, Mark Harnett, Adrian S. Dobs et al. · Journal of Andrology · 2010 · 66 citations

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

David Staskin, Mark Harnett · Current Urology Reports · 2004 · 51 citations

, , +4

1–5 of 15